Oncolytic virus therapy
CA 2442648 C · Owner: Pro-Virus, Inc. · Inventors: Mueller, Stephen N.; Groene, William S.; Miller, Jeffrey A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject the pharmaceutical , composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 9, 2002 and granted October 16, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.